| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 365,540 | 346,073 | 524,580 | | Cost of Revenue | 319,038 | 310,089 | 450,995 | | | Gross Profit | 46,502 | 35,984 | 73,585 | | | Operating Expenses | | Research Development | 6,940 | 6,433 | 27,302 | | Selling General and Administrative | 41,615 | 35,576 | 60,907 | | Non Recurring |
-
| (15,162) | 13,947 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,053) | 9,137 | (28,571) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,675) | 921 | (1,245) | | Earnings Before Interest And Taxes | (3,728) | 10,058 | (29,816) | | Interest Expense | 8,787 | 8,246 | 13,437 | | Income Before Tax | (12,515) | 1,812 | (43,253) | | Income Tax Expense | 1,993 | 1,063 | 4,094 | | Minority Interest | 565 | (2,931) | 1,273 | | | | Net Income From Continuing Ops | (13,943) | (2,182) | (46,074) | | | Non-recurring Events | | Discontinued Operations |
-
| (16,353) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (13,943) | (18,535) | (46,074) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($13,943) | ($18,535) | ($46,074) |
|
1.48% Nasdaq 
0.02 (1.21%) 
Income Statement
